Self-transfusion to protect bone marrow during cervical cancer treatment
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial studies whether returning your own blood stem cells back to you (from a processed blood sample) can help protect your bone marrow while you receive chemotherapy and/or radiation for cervical cancer. It may help reduce treatment-related damage to the bone marrow that produces blood cells.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18–60 years old and have cervical cancer that needs radiation and chemotherapy
- Your cervical cancer diagnosis is squamous cancer, adenocarcinoma, or adenosquamous cancer
- Your overall health is good enough for study visits (ECOG 0–1)
- You are expected to live more than 3 months
- If you can get pregnant: you are pre-menopausal and have a negative pregnancy test, and you agree to reliable birth control during the study and for 6 months after
- You do NOT have certain conditions like bone marrow disease, major metastases to brain/bone, or severe heart problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at giving chemotherapy with an added support step using your own collected stem cells. It may help people with recurrent or metastatic ovarian cancer by supporting bone marrow recovery while treatment continues.
This trial tests if giving back your own stored stem cells can help restore low blood cell counts that persist or develop 30 to 90 days after CAR-T therapy for multiple myeloma.
This trial studies a specific type of radiation (helical tomotherapy) in people with multiple myeloma who are planning an autologous stem cell transplant. It may help the study team understand how safe and effective this approach is when used during transplant preparation.
This trial tests giving patients their own stored stem cells after CAR-T therapy to help recover low blood counts. It is for people with B-cell non-Hodgkin lymphoma whose blood counts are still low after CAR-T and who have a stable response to treatment.
This trial tests a new approach for people with non-cancerous blood and immune system diseases. It uses your own engineered immune cells (CAR-T cells) to prepare your body for a stem cell transplant from a relative.
This trial tests whether it is safe to give blood transfusions at home instead of in the hospital. It is for people who need regular blood transfusions for their cancer care.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.